CJ Bioscience to launch microbiome analysis service in 2024

South Korea's CJ Bioscience Inc. announced on Friday that it plans to officially launch the microbe analysis platform "EzBiome Bioinformatics app" (EzBiome) next year.

EzBiome is a software-as-a-service (SaaS) microbial life information analysis platform. The company explained that it rapidly analyzes microbiome-related data to generate results that can be used in clinical trials and other applications.

Starting this month, the company is conducting a pilot service by opening some features to industry professionals and academic researchers, incorporating expert feedback before the official launch. It is also considering adopting artificial intelligence (AI) to analyze microbiome genomes. The company held a workshop on July 26 for industry professionals on the functionalities and applications of EzBiome.

"With the recent expansion of genome analysis services in hospitals and other facilities, the demand in the clinical and infectious disease diagnosis fields is growing, and the related market is expected to continue to grow," a CJ Bioscience source said. "We plan to provide a premium service based on world-class microbiome data analysis technology,"

The microbiome is a term that combines microorganisms and ecosystems, referring to the tens of trillions of microorganisms and their genes that exist in the human body. Among them, beneficial species are being utilized in pharmaceuticals and health-functional foods.

Write to Ye-Na Kim at yena@hankyung.com